Skip to main navigation Skip to search Skip to main content

A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease

  • MK-6024 P001 Study Group

Research output: Contribution to journal › Article › peer-review

213   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science